Pfizer seeks US Food and Drug Administration (FDA) approval to launch the much-anticipated Covid vaccine.
If approved, the vaccine will be available in the United States later this year.
Pfizer will submit the Covid vaccine to the U.S. for approval in early November.
Pfizer said tests of the wax, developed in collaboration with German company BioNTech, have been successful and the vaccine is expected to receive FDA approval by the end of November.
Currently, a clinical trial of the vaccine has been conducted on 40,000 people.
Pfizer Chief Executive Albert Bourla said he expects the vaccine to be approved for urgent use in the United States in the third week of November.
Pfizer’s application for the vaccine comes as the U.S. president promised that the vaccine will be released ahead of the presidential election.
However Pfizer acknowledged that the vaccine is not for anyone’s personal or political gain, instead they’ve brought out the vaccine to strengthen the hope of the world.
Mizuho analyst Vamil Divan said, that the marketing of the vaccine was only a small part of it.
He said people should be prepared to accept the vaccine and not be reluctant.
The world has stopped testing two vaccines for months following the discovery of unconfirmed diseases in those who received the vaccine.
Johnson & Johnson’s was suspended their vaccine trials as a participant felt ill. AstraZeneca and Oxford University vaccines were also discontinued in the United States.
At the same time, Pfizer is optimistic that Covid Wax will be approved and marketed.